Myeloproliferative neoplasms (MPN) are blood cancers that occur when the body makes too many white or red blood cells or platelets. A few of the MPNs are myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV).
Learn from experts about MPNs, how they are treated and the advances being made through research and clinical trials.
Upcoming EventsSee all events
Episode 7 of 14 in Facing MPN
Wednesday, October 21, 2020
Having to account for the logistical, emotional, and medical ramifications of COVID-19 is enough to drive anyone batty. For patients who are transfusion or phlebotomy dependent, the burden is even higher.